The increased plasma levels of both IL-1β and TNFα in COVID-19 patients (115, 116) suggest their potential contribution to increased ADAM17-mediated ACE2 shedding and consequently increased plasma Ang II and heightened renin-angiotensin system, leading to enhanced inflammation and triggering lung failure in COVID-19 patients. Here, ADAM17 is linked to COVID-19.